Conwell DL

No ORCID on file · 6 papers in corpus · active 2017-2024
2024
Pancreas ·doi:10.1097/mpa.0000000000002318

ObjectivesChronic pancreatitis (CP) is an inflammatory disease affecting the absorption of fat-soluble nutrients. Signaling in pancreatic cells that lead to inflammation may be influenced by fatty acids (FAs) through diet and de novo lipoge…

2024
Clinical and translational gastroenterology ·doi:10.14309/ctg.0000000000000686

IntroductionChronic pancreatitis (CP) is a progressive fibroinflammatory disorder lacking therapies and biomarkers. Neutrophil gelatinase-associated lipocalin (NGAL) is a proinflammatory cytokine elevated during inflammation that binds fatt…

2022
Pancreas ·doi:10.1097/mpa.0000000000002079

AbstractAcute pancreatitis (AP) is a disease characterized by an acute inflammatory phase followed by a convalescent phase. Diabetes mellitus (DM) was historically felt to be a transient phenomenon related to acute inflammation; however, it…

2022
Pancreas ·doi:10.1097/mpa.0000000000002063

ObjectivesTotal pancreatectomy with islet autotransplantation (TPIAT) is a surgical option for refractory chronic pancreatitis-related pain. Despite the known clinical implications of TPIAT, the molecular effects remain poorly investigated.…

2017
Proceedings of the National Academy of Sciences of the United States of America ·doi:10.1073/pnas.1620264114

Chronic pancreatitis (CP) is a progressive inflammatory disease of the pancreas, leading to its fibrotic destruction. There are currently no drugs that can stop or slow the progression of the disease. The etiology of the disease is multifac…

2017
Digestive diseases and sciences ·doi:10.1007/s10620-017-4621-z

Background/objectivesOur aim was to validate recent epidemiologic trends and describe the distribution of TIGAR-O risk factors in chronic pancreatitis (CP) patients.MethodsThe NAPS-2 Continuation and Validation (NAPS2-CV) study prospectivel…